-+ 0.00%
-+ 0.00%
-+ 0.00%
Nykode Therapeutics Participates in Fireside Chat at Guggenheim Healthcare Innovation Conference
Share
Listen to the news
Nykode Therapeutics Participates in Fireside Chat at Guggenheim Healthcare Innovation Conference
  • Nykode Therapeutics will attend Guggenheim Securities’ third Annual Healthcare Innovation Conference in Boston, Nov. 9-11, 2026.
  • CEO Michael Engsig and CSO Agnete Fredriksen will participate in a fireside chat Nov. 10 at 4 p.m. EST.
  • Management will meet investors individually and discuss cancer vaccine programs abi-suva and VB10.NEO, alongside its immune tolerance platform.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nykode Therapeutics AS published the original content used to generate this news brief via NewsWeb, the disclosure sustem operated by Euronext Oslo (Ref. ID: 202611050230OSLOBORSNEWS__EN_2B8B150A5AE38EE057C5E66A5D2B320), on November 05, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending